Clinics and Research in Hepatology and Gastroenterology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2104961, encodeId=d20c210496169, content=With editor状态大概会持续多久呀？非常感谢老师们的回复🌹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3c55329396, createdName=148c7100m03暂无昵称, createdTime=Thu Dec 08 18:39:36 CST 2022, time=2022-12-08, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2093681, encodeId=7e292093681ad, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：版面费要怎么交啊，一直没邮件？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9da5700071, createdName=ms5000000918858616, createdTime=Thu Oct 13 22:28:52 CST 2022, time=2022-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249130, encodeId=b90212491303c, content=审稿速度:3.0 偏重的研究方向：肝癌 经验分享：投稿2个多月，一直未找到合适的审稿人，然后给拒稿了。哈哈哈哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97a06490553, createdName=TMAC1992, createdTime=Thu Sep 15 17:41:44 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237970, encodeId=f02f123e970fc, content=偏重的研究方向：肝病;肝癌 经验分享：开始新的征程，实时分享投稿经历🤡别问我为啥是新征程，因为才被拒稿过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Thu Aug 11 00:51:40 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226465, encodeId=9bd41226465d2, content=under review一个多月了，为什么有的人很快，有的很慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Tue Jun 14 20:21:19 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222223, encodeId=a0971222223aa, content=审稿速度:1.0 偏重的研究方向：胃肠道 经验分享：给人感觉速度还可以，一篇小文章。 3.1投稿，3.28返修，4.14修回，5.4邮件接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211228/ab651ab2c3a7462dba3f4b878ae66b88/e032384801124a43bb5f615b6216d3b9.jpg, createdBy=72275425653, createdName=ms6000001002988625, createdTime=Wed May 25 07:16:03 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192810, encodeId=c1071192810a7, content=审稿速度:1.0 经验分享：Clinics and Research in Hepatology and Gastroenterology 胶囊内镜单纯临床回顾性研究，数据不新， 1.24号投稿，2.7号拒稿，审稿了并给出拒绝理由，创新性不够，投稿太多，速度挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Sat Feb 12 22:26:28 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104196, encodeId=6ccd1104196b3, content=文章投稿应该按照什么思路开始？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104195, encodeId=8f8611041957b, content=水刊真的不值得选择吗？什么情况下可选择水刊投稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807192, encodeId=572a80e192cf, content=两个月了，还在under review. 这么慢的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94665282539, createdName=14847382m81(暂无昵称), createdTime=Mon Aug 10 08:45:39 CST 2020, time=2020-08-10, status=1, ipAttribution=)]

2022-12-08 148c7100m03暂无昵称来自河南省

With editor状态大概会持续多久呀？非常感谢老师们的回复🌹

36 0

[GetPortalCommentsPageByObjectIdResponse(id=2104961, encodeId=d20c210496169, content=With editor状态大概会持续多久呀？非常感谢老师们的回复🌹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3c55329396, createdName=148c7100m03暂无昵称, createdTime=Thu Dec 08 18:39:36 CST 2022, time=2022-12-08, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2093681, encodeId=7e292093681ad, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：版面费要怎么交啊，一直没邮件？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9da5700071, createdName=ms5000000918858616, createdTime=Thu Oct 13 22:28:52 CST 2022, time=2022-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249130, encodeId=b90212491303c, content=审稿速度:3.0 偏重的研究方向：肝癌 经验分享：投稿2个多月，一直未找到合适的审稿人，然后给拒稿了。哈哈哈哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97a06490553, createdName=TMAC1992, createdTime=Thu Sep 15 17:41:44 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237970, encodeId=f02f123e970fc, content=偏重的研究方向：肝病;肝癌 经验分享：开始新的征程，实时分享投稿经历🤡别问我为啥是新征程，因为才被拒稿过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Thu Aug 11 00:51:40 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226465, encodeId=9bd41226465d2, content=under review一个多月了，为什么有的人很快，有的很慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Tue Jun 14 20:21:19 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222223, encodeId=a0971222223aa, content=审稿速度:1.0 偏重的研究方向：胃肠道 经验分享：给人感觉速度还可以，一篇小文章。 3.1投稿，3.28返修，4.14修回，5.4邮件接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211228/ab651ab2c3a7462dba3f4b878ae66b88/e032384801124a43bb5f615b6216d3b9.jpg, createdBy=72275425653, createdName=ms6000001002988625, createdTime=Wed May 25 07:16:03 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192810, encodeId=c1071192810a7, content=审稿速度:1.0 经验分享：Clinics and Research in Hepatology and Gastroenterology 胶囊内镜单纯临床回顾性研究，数据不新， 1.24号投稿，2.7号拒稿，审稿了并给出拒绝理由，创新性不够，投稿太多，速度挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Sat Feb 12 22:26:28 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104196, encodeId=6ccd1104196b3, content=文章投稿应该按照什么思路开始？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104195, encodeId=8f8611041957b, content=水刊真的不值得选择吗？什么情况下可选择水刊投稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807192, encodeId=572a80e192cf, content=两个月了，还在under review. 这么慢的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94665282539, createdName=14847382m81(暂无昵称), createdTime=Mon Aug 10 08:45:39 CST 2020, time=2020-08-10, status=1, ipAttribution=)]

2022-10-13 ms5000000918858616

审稿速度:3.0 | 投稿命中率:75.0
经验分享：版面费要怎么交啊，一直没邮件？

46 0

[GetPortalCommentsPageByObjectIdResponse(id=2104961, encodeId=d20c210496169, content=With editor状态大概会持续多久呀？非常感谢老师们的回复🌹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3c55329396, createdName=148c7100m03暂无昵称, createdTime=Thu Dec 08 18:39:36 CST 2022, time=2022-12-08, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2093681, encodeId=7e292093681ad, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：版面费要怎么交啊，一直没邮件？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9da5700071, createdName=ms5000000918858616, createdTime=Thu Oct 13 22:28:52 CST 2022, time=2022-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249130, encodeId=b90212491303c, content=审稿速度:3.0 偏重的研究方向：肝癌 经验分享：投稿2个多月，一直未找到合适的审稿人，然后给拒稿了。哈哈哈哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97a06490553, createdName=TMAC1992, createdTime=Thu Sep 15 17:41:44 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237970, encodeId=f02f123e970fc, content=偏重的研究方向：肝病;肝癌 经验分享：开始新的征程，实时分享投稿经历🤡别问我为啥是新征程，因为才被拒稿过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Thu Aug 11 00:51:40 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226465, encodeId=9bd41226465d2, content=under review一个多月了，为什么有的人很快，有的很慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Tue Jun 14 20:21:19 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222223, encodeId=a0971222223aa, content=审稿速度:1.0 偏重的研究方向：胃肠道 经验分享：给人感觉速度还可以，一篇小文章。 3.1投稿，3.28返修，4.14修回，5.4邮件接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211228/ab651ab2c3a7462dba3f4b878ae66b88/e032384801124a43bb5f615b6216d3b9.jpg, createdBy=72275425653, createdName=ms6000001002988625, createdTime=Wed May 25 07:16:03 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192810, encodeId=c1071192810a7, content=审稿速度:1.0 经验分享：Clinics and Research in Hepatology and Gastroenterology 胶囊内镜单纯临床回顾性研究，数据不新， 1.24号投稿，2.7号拒稿，审稿了并给出拒绝理由，创新性不够，投稿太多，速度挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Sat Feb 12 22:26:28 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104196, encodeId=6ccd1104196b3, content=文章投稿应该按照什么思路开始？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104195, encodeId=8f8611041957b, content=水刊真的不值得选择吗？什么情况下可选择水刊投稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807192, encodeId=572a80e192cf, content=两个月了，还在under review. 这么慢的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94665282539, createdName=14847382m81(暂无昵称), createdTime=Mon Aug 10 08:45:39 CST 2020, time=2020-08-10, status=1, ipAttribution=)]

2022-09-15 TMAC1992

审稿速度:3.0
偏重的研究方向：肝癌
经验分享：投稿2个多月，一直未找到合适的审稿人，然后给拒稿了。哈哈哈哈哈哈

37 0

[GetPortalCommentsPageByObjectIdResponse(id=2104961, encodeId=d20c210496169, content=With editor状态大概会持续多久呀？非常感谢老师们的回复🌹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3c55329396, createdName=148c7100m03暂无昵称, createdTime=Thu Dec 08 18:39:36 CST 2022, time=2022-12-08, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2093681, encodeId=7e292093681ad, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：版面费要怎么交啊，一直没邮件？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9da5700071, createdName=ms5000000918858616, createdTime=Thu Oct 13 22:28:52 CST 2022, time=2022-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249130, encodeId=b90212491303c, content=审稿速度:3.0 偏重的研究方向：肝癌 经验分享：投稿2个多月，一直未找到合适的审稿人，然后给拒稿了。哈哈哈哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97a06490553, createdName=TMAC1992, createdTime=Thu Sep 15 17:41:44 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237970, encodeId=f02f123e970fc, content=偏重的研究方向：肝病;肝癌 经验分享：开始新的征程，实时分享投稿经历🤡别问我为啥是新征程，因为才被拒稿过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Thu Aug 11 00:51:40 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226465, encodeId=9bd41226465d2, content=under review一个多月了，为什么有的人很快，有的很慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Tue Jun 14 20:21:19 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222223, encodeId=a0971222223aa, content=审稿速度:1.0 偏重的研究方向：胃肠道 经验分享：给人感觉速度还可以，一篇小文章。 3.1投稿，3.28返修，4.14修回，5.4邮件接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211228/ab651ab2c3a7462dba3f4b878ae66b88/e032384801124a43bb5f615b6216d3b9.jpg, createdBy=72275425653, createdName=ms6000001002988625, createdTime=Wed May 25 07:16:03 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192810, encodeId=c1071192810a7, content=审稿速度:1.0 经验分享：Clinics and Research in Hepatology and Gastroenterology 胶囊内镜单纯临床回顾性研究，数据不新， 1.24号投稿，2.7号拒稿，审稿了并给出拒绝理由，创新性不够，投稿太多，速度挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Sat Feb 12 22:26:28 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104196, encodeId=6ccd1104196b3, content=文章投稿应该按照什么思路开始？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104195, encodeId=8f8611041957b, content=水刊真的不值得选择吗？什么情况下可选择水刊投稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807192, encodeId=572a80e192cf, content=两个月了，还在under review. 这么慢的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94665282539, createdName=14847382m81(暂无昵称), createdTime=Mon Aug 10 08:45:39 CST 2020, time=2020-08-10, status=1, ipAttribution=)]

2022-08-11 Doctor小雷

偏重的研究方向：肝病;肝癌
经验分享：开始新的征程，实时分享投稿经历🤡别问我为啥是新征程，因为才被拒稿过

58 15

展开15条回复

[GetPortalCommentsPageByObjectIdResponse(id=2104961, encodeId=d20c210496169, content=With editor状态大概会持续多久呀？非常感谢老师们的回复🌹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3c55329396, createdName=148c7100m03暂无昵称, createdTime=Thu Dec 08 18:39:36 CST 2022, time=2022-12-08, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2093681, encodeId=7e292093681ad, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：版面费要怎么交啊，一直没邮件？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9da5700071, createdName=ms5000000918858616, createdTime=Thu Oct 13 22:28:52 CST 2022, time=2022-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249130, encodeId=b90212491303c, content=审稿速度:3.0 偏重的研究方向：肝癌 经验分享：投稿2个多月，一直未找到合适的审稿人，然后给拒稿了。哈哈哈哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97a06490553, createdName=TMAC1992, createdTime=Thu Sep 15 17:41:44 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237970, encodeId=f02f123e970fc, content=偏重的研究方向：肝病;肝癌 经验分享：开始新的征程，实时分享投稿经历🤡别问我为啥是新征程，因为才被拒稿过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Thu Aug 11 00:51:40 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226465, encodeId=9bd41226465d2, content=under review一个多月了，为什么有的人很快，有的很慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Tue Jun 14 20:21:19 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222223, encodeId=a0971222223aa, content=审稿速度:1.0 偏重的研究方向：胃肠道 经验分享：给人感觉速度还可以，一篇小文章。 3.1投稿，3.28返修，4.14修回，5.4邮件接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211228/ab651ab2c3a7462dba3f4b878ae66b88/e032384801124a43bb5f615b6216d3b9.jpg, createdBy=72275425653, createdName=ms6000001002988625, createdTime=Wed May 25 07:16:03 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192810, encodeId=c1071192810a7, content=审稿速度:1.0 经验分享：Clinics and Research in Hepatology and Gastroenterology 胶囊内镜单纯临床回顾性研究，数据不新， 1.24号投稿，2.7号拒稿，审稿了并给出拒绝理由，创新性不够，投稿太多，速度挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Sat Feb 12 22:26:28 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104196, encodeId=6ccd1104196b3, content=文章投稿应该按照什么思路开始？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104195, encodeId=8f8611041957b, content=水刊真的不值得选择吗？什么情况下可选择水刊投稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807192, encodeId=572a80e192cf, content=两个月了，还在under review. 这么慢的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94665282539, createdName=14847382m81(暂无昵称), createdTime=Mon Aug 10 08:45:39 CST 2020, time=2020-08-10, status=1, ipAttribution=)]

2022-06-14 xuanzixue02

under review一个多月了，为什么有的人很快，有的很慢啊

40 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2104961, encodeId=d20c210496169, content=With editor状态大概会持续多久呀？非常感谢老师们的回复🌹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3c55329396, createdName=148c7100m03暂无昵称, createdTime=Thu Dec 08 18:39:36 CST 2022, time=2022-12-08, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2093681, encodeId=7e292093681ad, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：版面费要怎么交啊，一直没邮件？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9da5700071, createdName=ms5000000918858616, createdTime=Thu Oct 13 22:28:52 CST 2022, time=2022-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249130, encodeId=b90212491303c, content=审稿速度:3.0 偏重的研究方向：肝癌 经验分享：投稿2个多月，一直未找到合适的审稿人，然后给拒稿了。哈哈哈哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97a06490553, createdName=TMAC1992, createdTime=Thu Sep 15 17:41:44 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237970, encodeId=f02f123e970fc, content=偏重的研究方向：肝病;肝癌 经验分享：开始新的征程，实时分享投稿经历🤡别问我为啥是新征程，因为才被拒稿过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Thu Aug 11 00:51:40 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226465, encodeId=9bd41226465d2, content=under review一个多月了，为什么有的人很快，有的很慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Tue Jun 14 20:21:19 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222223, encodeId=a0971222223aa, content=审稿速度:1.0 偏重的研究方向：胃肠道 经验分享：给人感觉速度还可以，一篇小文章。 3.1投稿，3.28返修，4.14修回，5.4邮件接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211228/ab651ab2c3a7462dba3f4b878ae66b88/e032384801124a43bb5f615b6216d3b9.jpg, createdBy=72275425653, createdName=ms6000001002988625, createdTime=Wed May 25 07:16:03 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192810, encodeId=c1071192810a7, content=审稿速度:1.0 经验分享：Clinics and Research in Hepatology and Gastroenterology 胶囊内镜单纯临床回顾性研究，数据不新， 1.24号投稿，2.7号拒稿，审稿了并给出拒绝理由，创新性不够，投稿太多，速度挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Sat Feb 12 22:26:28 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104196, encodeId=6ccd1104196b3, content=文章投稿应该按照什么思路开始？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104195, encodeId=8f8611041957b, content=水刊真的不值得选择吗？什么情况下可选择水刊投稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807192, encodeId=572a80e192cf, content=两个月了，还在under review. 这么慢的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94665282539, createdName=14847382m81(暂无昵称), createdTime=Mon Aug 10 08:45:39 CST 2020, time=2020-08-10, status=1, ipAttribution=)]

2022-05-25 ms6000001002988625

审稿速度:1.0
偏重的研究方向：胃肠道
经验分享：给人感觉速度还可以，一篇小文章。 3.1投稿，3.28返修，4.14修回，5.4邮件接收。

46 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2104961, encodeId=d20c210496169, content=With editor状态大概会持续多久呀？非常感谢老师们的回复🌹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3c55329396, createdName=148c7100m03暂无昵称, createdTime=Thu Dec 08 18:39:36 CST 2022, time=2022-12-08, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2093681, encodeId=7e292093681ad, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：版面费要怎么交啊，一直没邮件？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9da5700071, createdName=ms5000000918858616, createdTime=Thu Oct 13 22:28:52 CST 2022, time=2022-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249130, encodeId=b90212491303c, content=审稿速度:3.0 偏重的研究方向：肝癌 经验分享：投稿2个多月，一直未找到合适的审稿人，然后给拒稿了。哈哈哈哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97a06490553, createdName=TMAC1992, createdTime=Thu Sep 15 17:41:44 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237970, encodeId=f02f123e970fc, content=偏重的研究方向：肝病;肝癌 经验分享：开始新的征程，实时分享投稿经历🤡别问我为啥是新征程，因为才被拒稿过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Thu Aug 11 00:51:40 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226465, encodeId=9bd41226465d2, content=under review一个多月了，为什么有的人很快，有的很慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Tue Jun 14 20:21:19 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222223, encodeId=a0971222223aa, content=审稿速度:1.0 偏重的研究方向：胃肠道 经验分享：给人感觉速度还可以，一篇小文章。 3.1投稿，3.28返修，4.14修回，5.4邮件接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211228/ab651ab2c3a7462dba3f4b878ae66b88/e032384801124a43bb5f615b6216d3b9.jpg, createdBy=72275425653, createdName=ms6000001002988625, createdTime=Wed May 25 07:16:03 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192810, encodeId=c1071192810a7, content=审稿速度:1.0 经验分享：Clinics and Research in Hepatology and Gastroenterology 胶囊内镜单纯临床回顾性研究，数据不新， 1.24号投稿，2.7号拒稿，审稿了并给出拒绝理由，创新性不够，投稿太多，速度挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Sat Feb 12 22:26:28 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104196, encodeId=6ccd1104196b3, content=文章投稿应该按照什么思路开始？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104195, encodeId=8f8611041957b, content=水刊真的不值得选择吗？什么情况下可选择水刊投稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807192, encodeId=572a80e192cf, content=两个月了，还在under review. 这么慢的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94665282539, createdName=14847382m81(暂无昵称), createdTime=Mon Aug 10 08:45:39 CST 2020, time=2020-08-10, status=1, ipAttribution=)]

2022-02-12 ms2000000713462597

审稿速度:1.0
经验分享：Clinics and Research in Hepatology and Gastroenterology
胶囊内镜单纯临床回顾性研究，数据不新，
1.24号投稿，2.7号拒稿，审稿了并给出拒绝理由，创新性不够，投稿太多，速度挺快的

46 0

[GetPortalCommentsPageByObjectIdResponse(id=2104961, encodeId=d20c210496169, content=With editor状态大概会持续多久呀？非常感谢老师们的回复🌹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3c55329396, createdName=148c7100m03暂无昵称, createdTime=Thu Dec 08 18:39:36 CST 2022, time=2022-12-08, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2093681, encodeId=7e292093681ad, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：版面费要怎么交啊，一直没邮件？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9da5700071, createdName=ms5000000918858616, createdTime=Thu Oct 13 22:28:52 CST 2022, time=2022-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249130, encodeId=b90212491303c, content=审稿速度:3.0 偏重的研究方向：肝癌 经验分享：投稿2个多月，一直未找到合适的审稿人，然后给拒稿了。哈哈哈哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97a06490553, createdName=TMAC1992, createdTime=Thu Sep 15 17:41:44 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237970, encodeId=f02f123e970fc, content=偏重的研究方向：肝病;肝癌 经验分享：开始新的征程，实时分享投稿经历🤡别问我为啥是新征程，因为才被拒稿过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Thu Aug 11 00:51:40 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226465, encodeId=9bd41226465d2, content=under review一个多月了，为什么有的人很快，有的很慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Tue Jun 14 20:21:19 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222223, encodeId=a0971222223aa, content=审稿速度:1.0 偏重的研究方向：胃肠道 经验分享：给人感觉速度还可以，一篇小文章。 3.1投稿，3.28返修，4.14修回，5.4邮件接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211228/ab651ab2c3a7462dba3f4b878ae66b88/e032384801124a43bb5f615b6216d3b9.jpg, createdBy=72275425653, createdName=ms6000001002988625, createdTime=Wed May 25 07:16:03 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192810, encodeId=c1071192810a7, content=审稿速度:1.0 经验分享：Clinics and Research in Hepatology and Gastroenterology 胶囊内镜单纯临床回顾性研究，数据不新， 1.24号投稿，2.7号拒稿，审稿了并给出拒绝理由，创新性不够，投稿太多，速度挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Sat Feb 12 22:26:28 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104196, encodeId=6ccd1104196b3, content=文章投稿应该按照什么思路开始？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104195, encodeId=8f8611041957b, content=水刊真的不值得选择吗？什么情况下可选择水刊投稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807192, encodeId=572a80e192cf, content=两个月了，还在under review. 这么慢的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94665282539, createdName=14847382m81(暂无昵称), createdTime=Mon Aug 10 08:45:39 CST 2020, time=2020-08-10, status=1, ipAttribution=)]

2021-12-28 桑晒麦拉

文章投稿应该按照什么思路开始？

57 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2104961, encodeId=d20c210496169, content=With editor状态大概会持续多久呀？非常感谢老师们的回复🌹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3c55329396, createdName=148c7100m03暂无昵称, createdTime=Thu Dec 08 18:39:36 CST 2022, time=2022-12-08, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2093681, encodeId=7e292093681ad, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：版面费要怎么交啊，一直没邮件？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9da5700071, createdName=ms5000000918858616, createdTime=Thu Oct 13 22:28:52 CST 2022, time=2022-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249130, encodeId=b90212491303c, content=审稿速度:3.0 偏重的研究方向：肝癌 经验分享：投稿2个多月，一直未找到合适的审稿人，然后给拒稿了。哈哈哈哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97a06490553, createdName=TMAC1992, createdTime=Thu Sep 15 17:41:44 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237970, encodeId=f02f123e970fc, content=偏重的研究方向：肝病;肝癌 经验分享：开始新的征程，实时分享投稿经历🤡别问我为啥是新征程，因为才被拒稿过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Thu Aug 11 00:51:40 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226465, encodeId=9bd41226465d2, content=under review一个多月了，为什么有的人很快，有的很慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Tue Jun 14 20:21:19 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222223, encodeId=a0971222223aa, content=审稿速度:1.0 偏重的研究方向：胃肠道 经验分享：给人感觉速度还可以，一篇小文章。 3.1投稿，3.28返修，4.14修回，5.4邮件接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211228/ab651ab2c3a7462dba3f4b878ae66b88/e032384801124a43bb5f615b6216d3b9.jpg, createdBy=72275425653, createdName=ms6000001002988625, createdTime=Wed May 25 07:16:03 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192810, encodeId=c1071192810a7, content=审稿速度:1.0 经验分享：Clinics and Research in Hepatology and Gastroenterology 胶囊内镜单纯临床回顾性研究，数据不新， 1.24号投稿，2.7号拒稿，审稿了并给出拒绝理由，创新性不够，投稿太多，速度挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Sat Feb 12 22:26:28 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104196, encodeId=6ccd1104196b3, content=文章投稿应该按照什么思路开始？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104195, encodeId=8f8611041957b, content=水刊真的不值得选择吗？什么情况下可选择水刊投稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807192, encodeId=572a80e192cf, content=两个月了，还在under review. 这么慢的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94665282539, createdName=14847382m81(暂无昵称), createdTime=Mon Aug 10 08:45:39 CST 2020, time=2020-08-10, status=1, ipAttribution=)]

2021-12-28 MS68862005

水刊真的不值得选择吗？什么情况下可选择水刊投稿？

52 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2104961, encodeId=d20c210496169, content=With editor状态大概会持续多久呀？非常感谢老师们的回复🌹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3c55329396, createdName=148c7100m03暂无昵称, createdTime=Thu Dec 08 18:39:36 CST 2022, time=2022-12-08, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2093681, encodeId=7e292093681ad, content=审稿速度:3.0 | 投稿命中率:75.0 经验分享：版面费要怎么交啊，一直没邮件？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9da5700071, createdName=ms5000000918858616, createdTime=Thu Oct 13 22:28:52 CST 2022, time=2022-10-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1249130, encodeId=b90212491303c, content=审稿速度:3.0 偏重的研究方向：肝癌 经验分享：投稿2个多月，一直未找到合适的审稿人，然后给拒稿了。哈哈哈哈哈哈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=97a06490553, createdName=TMAC1992, createdTime=Thu Sep 15 17:41:44 CST 2022, time=2022-09-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1237970, encodeId=f02f123e970fc, content=偏重的研究方向：肝病;肝癌 经验分享：开始新的征程，实时分享投稿经历🤡别问我为啥是新征程，因为才被拒稿过, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=48368189311, createdName=Doctor小雷, createdTime=Thu Aug 11 00:51:40 CST 2022, time=2022-08-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1226465, encodeId=9bd41226465d2, content=under review一个多月了，为什么有的人很快，有的很慢啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=40, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEI3zeibZYD2dhYUO1jtIuiba5ZF0xDBEMQSCZ5rEQURQTGm4gStABwRBsbcMuMkBshuQSqhUpklTheg/132, createdBy=3ecb1682603, createdName=xuanzixue02, createdTime=Tue Jun 14 20:21:19 CST 2022, time=2022-06-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222223, encodeId=a0971222223aa, content=审稿速度:1.0 偏重的研究方向：胃肠道 经验分享：给人感觉速度还可以，一篇小文章。 3.1投稿，3.28返修，4.14修回，5.4邮件接收。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211228/ab651ab2c3a7462dba3f4b878ae66b88/e032384801124a43bb5f615b6216d3b9.jpg, createdBy=72275425653, createdName=ms6000001002988625, createdTime=Wed May 25 07:16:03 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1192810, encodeId=c1071192810a7, content=审稿速度:1.0 经验分享：Clinics and Research in Hepatology and Gastroenterology 胶囊内镜单纯临床回顾性研究，数据不新， 1.24号投稿，2.7号拒稿，审稿了并给出拒绝理由，创新性不够，投稿太多，速度挺快的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74665434563, createdName=ms2000000713462597, createdTime=Sat Feb 12 22:26:28 CST 2022, time=2022-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104196, encodeId=6ccd1104196b3, content=文章投稿应该按照什么思路开始？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=57, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/72cbdf927f7647bd84938927488b4795/94fe7f0fd8274d94807c5f3458f0c4e2.jpg, createdBy=9cd75497899, createdName=桑晒麦拉, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1104195, encodeId=8f8611041957b, content=水刊真的不值得选择吗？什么情况下可选择水刊投稿？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=807192, encodeId=572a80e192cf, content=两个月了，还在under review. 这么慢的嘛, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=150, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=94665282539, createdName=14847382m81(暂无昵称), createdTime=Mon Aug 10 08:45:39 CST 2020, time=2020-08-10, status=1, ipAttribution=)]

2020-08-10 14847382m81(暂无昵称)

两个月了，还在under review. 这么慢的嘛

150 3

展开3条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务